Showing results (371-380 of 439) with videos related to

Sort By:
Pageof 44
European Journal of Pain (London, England)|February 22, 2025
The Efficacy and Safety of Botulinum Neurotoxin Type A in Treating Chronic Low Back Pain: A Systematic Review, Meta-Analysis, Trial Sequential Analysis, and Meta-RegressionWaseem Wagrees, Hesham Kelani, Hazem Mohamed Salamah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group StudyAnita L Sabichi, J Jack Lee, Robert J Taylor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2021
A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695)Thomas W Flaig, Catherine M Tangen, Siamak Daneshmand, et al.
Journal of Clinical Psychology in Medical Settings|October 15, 2025
Effectiveness of Individual Psychoeducational Interventions for Caregivers of Stroke Patients: A Systematic Review and Meta-AnalysisHesham Kelani, Hossam Tharwat Ali, Ahmed Naeem, et al.
European Urology|July 6, 2023
Long-term Outcomes from a Phase 2 Study of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer (SWOG S1314; NCT02177695)Thomas W Flaig, Catherine M Tangen, Siamak Daneshmand, et al.
The Journal of Urology|July 21, 2009
p53 predictive value for pT1-2 N0 disease at radical cystectomyShahrokh F Shariat, Yair Lotan, Pierre I Karakiewicz, et al.
European Urology|March 21, 2020
Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder CancerHugh Mostafid, Marko Babjuk, Bernard Bochner, et al.
BJU International|November 20, 2010
Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomyGuru Sonpavde, Myrna M Khan, Robert S Svatek, et al.
Pageof 44